Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF Save Sight Registries Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF Read More »
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry Save Sight Registries Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry Read More »
Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia Save Sight Registries Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia Read More »
Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project Save Sight Registries Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project Read More »
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration Save Sight Registries Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration Read More »
Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration Save Sight Registries Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration Read More »
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Save Sight Registries Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Read More »
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study Save Sight Registries Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study Read More »
Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries Save Sight Registries Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries Read More »
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry Save Sight Registries Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry Read More »
Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Save Sight Registries Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Read More »
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry Save Sight Registries Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry Read More »
